CoChat

Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting

Open access
Liu, Yang, Méric, Guillaume, Havulinna, Aki S., Teo, Shu Mei, Åberg, Fredrik, Ruuskanen, Matti, Sanders, Jon, Zhu, Qiyun, Tripathi, Anupriya, Verspoor, Karin, Cheng, Susan, Jain, Mohit, Jousilahti, Pekka, Vázquez-Baeza, Yoshiki, Loomba, Rohit, Lahti, Leo, Niiranen, Teemu, Salomaa, Veikko, Knight, Rob, Inouye, Michael · 2022 · Cell Metabolism
Cited by 104

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Gut microbiome sequencing has shown promise as a predictive biomarker for a wide range of diseases, including classification of liver disease and severity grading. However, the potential of gut microbiota for prospective risk prediction of liver disease has not been assessed. Here, we utilise shallow gut metagenomic sequencing data of a large population-based cohort (N=>7,115) and ∼15 years of electronic health register follow-up together with machine-learning to investigate the predictive capacity of gut microbial predictors, individually and in conjunction with conventional risk factors, for incident liver disease and alcoholic liver disease. Separately, conventional and microbiome risk factors showed comparable predictive capacity for incident liver disease. However, microbiome augmentation of conventional risk factor models using gradient boosted classifiers significantly improved performance, with average AUROCs of 0.834 for incident liver disease and 0.956 for alcoholic liver disease (AUPRCs of 0.185 and 0.304, respectively). Disease-free survival analysis showed significantly improved stratification using microbiome-augmented risk models as compared to conventional risk factors alone. Investigation of predictive microbial signatures revealed a wide range of bacterial taxa, including those previously associated with hepatic function and disease. This study supports the potential clinical validity of gut metagenomic sequencing to complement conventional risk factors for risk prediction of liver diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2022.03.002

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 104

Metadata

Authors
Liu, Y., Méric, G., Havulinna, A. S., Teo, S. M., Åberg, F., Ruuskanen, M., Sanders, J., Zhu, Q., Tripathi, A., Verspoor, K., Cheng, S., Jain, M., Jousilahti, P., Vázquez-Baeza, Y., Loomba, R., Lahti, L., Niiranen, T., Salomaa, V., Knight, R., & Inouye, M.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2022-05
Volume
34
Issue
5
Pages
719-730.e4
ISSN
1550-4131 (ISSN-L)
OpenAlex
W4221129774
Cited by
104
References
21
FWCI
5.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting. https://app.cochat.ai/papers/10.1016/j.cmet.2022.03.002
The paper
Liu, Y., Méric, G., Havulinna, A. S., Teo, S. M., Åberg, F., Ruuskanen, M., Sanders, J., Zhu, Q., Tripathi, A., Verspoor, K., Cheng, S., Jain, M., Jousilahti, P., Vázquez-Baeza, Y., Loomba, R., Lahti, L., Niiranen, T., Salomaa, V., Knight, R., & Inouye, M. (2022). Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting. Cell Metabolism. https://doi.org/10.1016/j.cmet.2022.03.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.